Avanos

Avanos Medical, Inc. Reports Preliminary Fourth Quarter and Full-Year 2023 Financial Results; Revises Preliminary 2024 Revenue Outlook

Retrieved on: 
Thursday, January 4, 2024

ALPHARETTA, Ga., Jan. 4, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for 2024.

Key Points: 
  • ALPHARETTA, Ga., Jan. 4, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for 2024.
  • The Company estimates that net sales for the HA product line will be slightly above $10 million for the fourth quarter of 2023, which is approximately $4 million lower than anticipated.
  • The Company will provide additional information regarding its outlook for 2024 on the conference call it will host to discuss its financial results for the quarter and year ended December 31, 2023, which is currently scheduled for February 20, 2024.
  • The Company does not intend to update such financial information prior to release of its financial statement information for the quarter and year ended December 31, 2023, which is currently scheduled for February 20, 2024.

Avanos Medical Supports New Interventional Procedure Recommendations from the UK's National Institute of Health and Care Excellence (NICE)

Retrieved on: 
Wednesday, June 28, 2023

ALPHARETTA, Ga., June 28, 2023 /PRNewswire/ -- Avanos Medical supports the announcement today from the UK's National Institute for Health and Care Excellence (NICE) recommending the use of radiofrequency ablation (RFA) for the treatment of osteoarthritic knee pain.

Key Points: 
  • ALPHARETTA, Ga., June 28, 2023 /PRNewswire/ -- Avanos Medical supports the announcement today from the UK's National Institute for Health and Care Excellence (NICE) recommending the use of radiofrequency ablation (RFA) for the treatment of osteoarthritic knee pain.
  • The radiofrequency energy can be delivered as conventional radiofrequency, cooled radiofrequency or pulsed radiofrequency.
  • "We are extremely pleased with today's interventional procedure recommendation by NICE," commented Dieter Krines, Avanos Vice President & General Manager, Europe.
  • I hope this will now help to increase awareness of this innovative therapy leading to improved outcomes for many more patients."

Avanos Medical Supports New Interventional Procedure Recommendations from the UK's National Institute of Health and Care Excellence (NICE)

Retrieved on: 
Wednesday, June 28, 2023

ALPHARETTA, Ga., June 28, 2023 /PRNewswire/ -- Avanos Medical supports the announcement today from the UK's National Institute for Health and Care Excellence (NICE) recommending the use of radiofrequency ablation (RFA) for the treatment of osteoarthritic knee pain.

Key Points: 
  • ALPHARETTA, Ga., June 28, 2023 /PRNewswire/ -- Avanos Medical supports the announcement today from the UK's National Institute for Health and Care Excellence (NICE) recommending the use of radiofrequency ablation (RFA) for the treatment of osteoarthritic knee pain.
  • The radiofrequency energy can be delivered as conventional radiofrequency, cooled radiofrequency or pulsed radiofrequency.
  • "We are extremely pleased with today's interventional procedure recommendation by NICE," commented Dieter Krines, Avanos Vice President & General Manager, Europe.
  • I hope this will now help to increase awareness of this innovative therapy leading to improved outcomes for many more patients."

Avanos Medical, Inc. Announces Agreement to Acquire Diros Technology Inc.

Retrieved on: 
Monday, June 19, 2023

ALPHARETTA, Ga., June 19, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire Diros Technology Inc., a leading manufacturer of innovative radiofrequency (RF) products used to treat chronic pain conditions.

Key Points: 
  • ALPHARETTA, Ga., June 19, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire Diros Technology Inc., a leading manufacturer of innovative radiofrequency (RF) products used to treat chronic pain conditions.
  • Based in Toronto, Canada, Diros Technology has been at the forefront of radiofrequency ablation (RFA) technology since its founding.
  • The addition of Diros' unique RF Trident™ technology is expected to further enhance Avanos' pain management treatment options and complement its premium COOLIEF* Cooled Radiofrequency product offering.
  • "The acquisition of Diros Technology strengthens Avanos' leadership position in RF technology by providing a full range of high-quality, differentiated pain management products," said Avanos Chief Executive Officer, Joe Woody.

Avanos Medical, Inc. To Host Investor Day on June 20, 2023

Retrieved on: 
Tuesday, June 13, 2023

ALPHARETTA, Ga., June 13, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it will host an Investor Day at Convene on 101 Park Avenue, New York, on Tuesday, June 20th, 2023.

Key Points: 
  • ALPHARETTA, Ga., June 13, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it will host an Investor Day at Convene on 101 Park Avenue, New York, on Tuesday, June 20th, 2023.
  • Chief Executive Officer Joe Woody, and SVP, Chief Financial Officer and Chief Transformation Officer, Michael Greiner, along with key members of Avanos' senior management team, will discuss the company's commercial optimization, innovation, supply chain effectiveness, and financial transformation.
  • Formal presentations followed by a question and answer session will begin at 1 p.m.
  • ET.

P&G and Avanos Receive OMP Awards for Supply Chain Innovation

Retrieved on: 
Thursday, September 1, 2022

P&G's recognition came after its sustained driveto develop and deploy groundbreaking supply chain planning concepts in partnership with OMP over the past 20+ years.

Key Points: 
  • P&G's recognition came after its sustained driveto develop and deploy groundbreaking supply chain planning concepts in partnership with OMP over the past 20+ years.
  • Avanos Medical received the OMP Co-Innovation Award for its contribution to OMP's next-generation software architecture, designed for scale and performance.
  • The OMP Awards program aims to honor companies in the OMP Community who push the boundaries of supply chain planning, thereby encouraging OMP to further reinforce its strategy and deployment capacity.
  • Recognized as a Gartner Supply Chain Master for several years, P&G receivedthe OMP Partnership Award for its long-term commitment to investing in supply chain planning excellence.In recent years, the company has developed the pioneering value stream management approach to supply chain planning based on full end-to-end visibility, powered by OMP's Unison PlanningTM .

Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2021 Financial Results

Retrieved on: 
Tuesday, July 27, 2021

ALPHARETTA, Ga., July 27, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2021 on Tuesday, August 3 at 9 a.m.

Key Points: 
  • ALPHARETTA, Ga., July 27, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2021 on Tuesday, August 3 at 9 a.m.
  • The company will issue a news release detailing its results before the market opens that same day.
  • The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer.
  • A simultaneous webcast of the call and a related presentation will be accessible via the Investors section of the Avanos Medical website, https://avanos.investorroom.com/.

Avanos Medical, Inc. to Present at the 2021 Raymond James Human Health Innovation Conference

Retrieved on: 
Friday, June 18, 2021

ALPHARETTA, Ga., June18, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present and participate in an analyst-led fireside chat at the Virtual 2021 Raymond James Human Health Innovation Conference Tues., June 22 at approximately 10:40 a.m., ET.

Key Points: 
  • ALPHARETTA, Ga., June18, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present and participate in an analyst-led fireside chat at the Virtual 2021 Raymond James Human Health Innovation Conference Tues., June 22 at approximately 10:40 a.m., ET.
  • A live webcast of conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.
  • Avanos develops, manufactures and markets its recognized brands in more than 90 countries.
  • For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.

Avanos Medical, Inc. To Webcast Conference Call Discussing First Quarter 2021 Financial Results

Retrieved on: 
Friday, April 30, 2021

b'ALPHARETTA, Ga., April 30, 2021 /PRNewswire/ --Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Friday, May 7 at 9 a.m.

Key Points: 
  • b'ALPHARETTA, Ga., April 30, 2021 /PRNewswire/ --Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Friday, May 7 at 9 a.m.
  • ET.
  • Avanos develops, manufactures and markets its recognized brands in more than 90 countries.
  • For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-co...\n'

Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual Institutional Investors Conference

Retrieved on: 
Wednesday, February 24, 2021

ALPHARETTA, Ga., Feb.24, 2021 /PRNewswire/ --Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raymond James 42nd Annual Institutional Investors Conference Mon., March 1 at approximately 3:50 p.m., ET

Key Points: 
  • ALPHARETTA, Ga., Feb.24, 2021 /PRNewswire/ --Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raymond James 42nd Annual Institutional Investors Conference Mon., March 1 at approximately 3:50 p.m., ET
    A live webcast of conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.
  • Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life.Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.
  • Avanos develops, manufactures and markets its recognized brands in more than 90 countries.
  • For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.